These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12811231)

  • 1. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity.
    Perazella MA
    Am J Med Sci; 2003 Jun; 325(6):349-62. PubMed ID: 12811231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.
    Perazella MA; Tray K
    Am J Med; 2001 Jul; 111(1):64-7. PubMed ID: 11448662
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors.
    Gambaro G; Perazella MA
    J Intern Med; 2003 Jun; 253(6):643-52. PubMed ID: 12755960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drug-induced nephrotoxicity.
    Izzedine H; Launay-Vacher V; Deray G
    Am J Kidney Dis; 2005 May; 45(5):804-17. PubMed ID: 15861345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
    Chiolero A; Würzner G; Burnier M
    Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 inhibitors and the kidney.
    Appel GB
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S37-40. PubMed ID: 11695250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe?
    Eras J; Perazella MA
    Am J Med Sci; 2001 Mar; 321(3):181-90. PubMed ID: 11269794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.
    Khan KN; Venturini CM; Bunch RT; Brassard JA; Koki AT; Morris DL; Trump BF; Maziasz TJ; Alden CL
    Toxicol Pathol; 1998; 26(5):612-20. PubMed ID: 9789947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors.
    Whelton A
    Am J Med; 2001 Feb; 110 Suppl 3A():33S-42S. PubMed ID: 11173048
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
    Zaragoza A; Llorente MJ; García MM; Ramírez JJ; Lloret G; Machancoses A
    Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
    [No Abstract]   [Full Text] [Related]  

  • 13. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
    Feldman M; McMahon AT
    Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
    [No Abstract]   [Full Text] [Related]  

  • 14. The coxibs, selective inhibitors of cyclooxygenase-2.
    Nzerue CM
    N Engl J Med; 2001 Dec; 345(23):1708-9. PubMed ID: 11759655
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.
    Noroian G; Clive D
    Drug Saf; 2002; 25(3):165-72. PubMed ID: 11945113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer?
    Gambaro G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1159-62. PubMed ID: 12105234
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COX-2 specific inhibitors are similar--and different].
    Aly A
    Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2 selectivity in gastroenterology].
    Ledro Cano D; Gómez Rodríguez BJ; Torres Domínguez Y; Hergueta Delgado P; Herrerías Esteban JM; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 1999 Apr; 91(4):305-9. PubMed ID: 10348929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.